Literature DB >> 24124656

Clinical relevance of routinely measured vital signs in hospitalized patients: a systematic review.

Marja N Storm-Versloot1, Lotte Verweij, Cees Lucas, Jeroen Ludikhuize, J Carel Goslings, Dink A Legemate, Hester Vermeulen.   

Abstract

BACKGROUND: Conflicting evidence exists on the effectiveness of routinely measured vital signs on the early detection of increased probability of adverse events.
PURPOSE: To assess the clinical relevance of routinely measured vital signs in medically and surgically hospitalized patients through a systematic review. DATA SOURCES: MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Cumulative Index to Nursing and Allied Health Literature, and Meta-analysen van diagnostisch onderzoek (in Dutch; MEDION) were searched to January 2013. STUDY SELECTION: Prospective studies evaluating routine vital sign measurements of hospitalized patients, in relation to mortality, septic or circulatory shock, intensive care unit admission, bleeding, reoperation, or infection. DATA EXTRACTION: Two reviewers independently assessed potential bias and extracted data to calculate likelihood ratios (LRs) and predictive values. DATA SYNTHESIS: Fifteen studies were performed in medical (n = 7), surgical (n = 4), or combined patient populations (n = 4; totaling 42,565 participants). Only three studies were relatively free from potential bias. For temperature, the positive LR (LR+) ranged from 0 to 9.88 (median 1.78; n = 9 studies); heart rate 0.82 to 6.79 (median 1.51; n = 5 studies); blood pressure 0.72 to 4.7 (median 2.97; n = 4 studies); oxygen saturation 0.65 to 6.35 (median 1.74; n = 2 studies); and respiratory rate 1.27 to 1.89 (n = 3 studies). Overall, three studies reported area under the Receiver Operator Characteristic (ROC) curve (AUC) data, ranging from 0.59 to 0.76. Two studies reported on combined vital signs, in which one study found an LR+ of 47.0, but in the other the AUC was not influenced.
CONCLUSIONS: Some discriminative LR+ were found, suggesting the clinical relevance of routine vital sign measurements. However, the subject is poorly studied, and many studies have methodological flaws. Further rigorous research is needed specifically intended to investigate the clinical relevance of routinely measured vital signs. CLINICAL RELEVANCE: The results of this research are important for clinical nurses to underpin daily routine practices and clinical decision making.
© 2013 Sigma Theta Tau International.

Entities:  

Keywords:  Systematic review; blood gas monitoring; hospital; prognosis; transcutaneous; vital signs

Mesh:

Year:  2013        PMID: 24124656     DOI: 10.1111/jnu.12048

Source DB:  PubMed          Journal:  J Nurs Scholarsh        ISSN: 1527-6546            Impact factor:   3.176


  5 in total

1.  Emergency Department Vital Signs and Outcomes After Discharge.

Authors:  Gelareh Z Gabayan; Michael K Gould; Robert E Weiss; Stephen F Derose; Vicki Y Chiu; Catherine A Sarkisian
Journal:  Acad Emerg Med       Date:  2017-07       Impact factor: 3.451

2.  Delayed Recognition of Deterioration of Patients in General Wards Is Mostly Caused by Human Related Monitoring Failures: A Root Cause Analysis of Unplanned ICU Admissions.

Authors:  Louise S van Galen; Patricia W Struik; Babiche E J M Driesen; Hanneke Merten; Jeroen Ludikhuize; Johannes I van der Spoel; Mark H H Kramer; Prabath W B Nanayakkara
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

Review 3.  Real Time Analysis of Bioanalytes in Healthcare, Food, Zoology and Botany.

Authors:  Tianqi Wang; Ashwin Ramnarayanan; Huanyu Cheng
Journal:  Sensors (Basel)       Date:  2017-12-21       Impact factor: 3.576

4.  Nursing assessment of continuous vital sign surveillance to improve patient safety on the medical/surgical unit.

Authors:  Terri Watkins; Lynn Whisman; Pamela Booker
Journal:  J Clin Nurs       Date:  2015-11-04       Impact factor: 3.036

5.  Factors related to monitoring during admission of acute patients.

Authors:  Thomas Schmidt; Camilla N Bech; Mikkel Brabrand; Uffe Kock Wiil; Annmarie Lassen
Journal:  J Clin Monit Comput       Date:  2016-04-12       Impact factor: 2.502

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.